All four major, English-language, Canadian networks will once again simulcast the Stand Up To Cancer (SUC2) fundraising telecast on Friday, Sept. 7.
For the third time, Stand Up To Cancer Canada will simultaneously broadcast a Canada-inclusive special across CBC, Citytv, CTV, and Global, as well as AMI, A.Side, BBC Earth, CHCH, CHEK, Cottage Life, Fight Network, Game TV, HIFI, Hollywood Suite, Love Nature, Makeful, NTV, OUTtv, Smithsonian Channel Canada, T+E, and YES TV (8 – 9 P.M. ET/PT / 7 P.M. CT).
The broadcast will stream live on the CBC TV App, cbc.ca/watch, CBS All Access, CTV GO and CTV.ca, Global GO and GlobalTV.com, and be available on-demand on TELUS Optik TV in Canada. It will also stream live in Toronto’s Yonge-Dundas Square on Bell Media’s Astral large-format digital screens and the Citytv Big Screen.
Broadcast live from The Barker Hangar in Santa Monica, CA, stars confirmed to take part in the sixth biennial event include Mahershala Ali, Kathy Bates, Katie Couric, Jennifer Garner, Tony Hale, Marg Helgenberger, Ed Helms, Ken Jeong, Marlee Matlin, Matthew McConaughey, Maria Menounos, Jillian Michaels, Trevor Noah, Dak Prescott, Rob Riggle, Karla Souza, David Spade, Keith Urban, Reese Witherspoon and Canadian Italia Ricci (Designated Survivor).
Bradley Cooper returns as co-executive producer, along with live-event producing team Done + Dusted.
“As someone whose family has been significantly touched by cancer, I am proud to again have the privilege of co-executive producing this year’s Stand Up To Cancer telecast,” said Cooper. “This show reminds everyone that you are never alone…that there is a community of support out there when you need it most. That’s the power of SU2C. Most importantly, the telecast showcases the significant progress being made in the fight against cancer, instilling hope in those facing the disease. This one-hour broadcast unites us all to raise funds for more effective treatments to save lives now.”
To date, more than $480 million (USD) has been pledged in support of SU2C’s innovative cancer research. The organization has brought together more than 1,500 scientists from over 180 leading institutions with an emphasis on collaborative, multidisciplinary teams that deliver new therapies and treatments to cancer patients.
In just under 10 years, SU2C research has contributed to FDA approval of five new cancer therapies, including treatments for breast, ovarian, and pancreatic cancers and difficult-to-treat leukemias. AACR International-Canada, the official Scientific Partner of Stand Up To Cancer Canada, is responsible for administering the grants and providing scientific oversight in conjunction with the SU2C Canada Scientific Advisory Committee (SAC), co-chaired by Alan Bernstein, president of the Canadian Institute for Advanced Research (CIFAR), and Nobel laureate Phillip A. Sharp, Ph.D., Institute professor, David H. Koch Institute for Integrative Cancer Research, MIT.
Stand Up To Cancer Canada currently has two pan-Canadian “Dream Teams” of top researchers:
- The Canadian Cancer Society (CCS) is a collaborator in the Stand Up To Cancer Canada-Canadian Cancer Society Breast Cancer Dream Team, along with the Ontario Institute for Cancer Research (OICR). The team is led by Tak W. Mak, Ph.D., director of the Campbell Family Institute for Breast Cancer Research at Princess Margaret Cancer Centre in Toronto, and co-leader Samuel Aparicio, BM, BCh, Ph.D., the Nan and Lorraine Robertson Chair in Breast Cancer Research at the University of British Columbia.
- Collaborators in the Stand Up To Cancer Canada Cancer Stem Cell Dream Team include the Canadian Institutes of Health Research (CIHR) Cancer Stem Cell Consortium, Genome Canada, and OICR. It’s led by Peter Dirks, M.D., Ph.D., neurosurgeon and senior scientist at The Hospital for Sick Children (SickKids) in Toronto, and co-leader Samuel Weiss, Ph.D., director of the Hotchkiss Brain Institute and professor in the Cumming School of Medicine at the University of Calgary.
